Mailed DNA tests could help families catch cancer early
NCT ID NCT06284330
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study looked at whether mailing at-home genetic testing kits to relatives of people with hereditary cancer gene variants could increase the number of relatives who get tested. Researchers compared this approach to usual care in 108 participants. The goal was to see if making testing easier helps families learn about their cancer risk.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Direct mailed at-home genetic testing kit
- What this could lead to
- If successful, this approach could help more at-risk relatives get tested for hereditary cancer genes, potentially catching cancer earlier.
- What could go wrong
- This is a small feasibility study (108 participants) in one state, so results may not apply broadly. The intervention may not significantly increase testing rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a digital guide boost genetic testing in prostate cancer survivors?
- New digital platform aims to break the silence around hereditary cancer in families
- New study aims to unlock why lynch syndrome patients still get cancer despite surveillance
- Can a website replace the genetic counselor? new study tests online cancer risk testing
- 50,000 samples to unlock secrets of hereditary tumors
- Chatbot aims to close genetic testing gap for black cancer survivors